A study by scientists at British American Tobacco has shown then when smokers switch completely to glo, their exposure to harmful smoke chemicals is substantially reduced, in some cases to levels comparable to those seen in smokers who quit smoking completely
Our industry-leading science and Next Generation Products have been showcased in our latest Science and Technology Report.
We’re presenting some of our latest in vitro data on next-generation products and taking part in workshops discussing latest developments in biological assessment.
Next week our scientists are visiting San Antonio for the annual Society of Toxicology (SOT) conference.
E-cigarette vapour does not induce DNA mutations commonly observed with tobacco smoke exposures in lab-based tests.
Toxicant levels in vapour from glo™ were found to be around 90%* less than in cigarette smoke. gloTM, a tobacco-heating product, heats rather than burns tobacco and operates at much lower temperatures than a lit cigarette
Scientists at British American Tobacco have conducted a series of tests, the results of which help establish glo™ as having the potential to be substantially reduced risk compared to traditional cigarettes
Papers 5, 6, and 7 of the glo Special Issue detail the studies of the biological in vittro effects that glo vapour has on human cells.
Scientists at (BAT) have created the most comprehensive database of scientific test results, to date, for an e-cigarette (Vype ePen). The results of the studies provide evidence that suggests Vype ePen has the potential to be substantially reduced risk compared to traditional cigarettes.
The identification of these genes could eventually lead to the development of plants that require less nitrogen and to the reduction of certain toxicants in smoke
A new laboratory study reveals that cigarette smoke completely prevented wound healing at concentrations over 20% in a wound healing assay, whereas e-cigarette vapour had no effect, even at 100% concentration and double the amount of nicotine relative to smoke
Biological testing using aerosols from several tobacco heating products found them to have little or no impact on human cells in the lab
Scientists tested vapour produced by a hybrid tobacco device, iFuse, and compared it to that produced by an e-cigarette, Vype ePen
Scientists at British American Tobacco have developed a technique that can detect unpredicted substances in e-cigarette vapour.
The first practical guide to the allergy-safe use of ingredients, such as flavourings, in e-liquid has been published.
A new study found no evidence that vapour from a commercially available e-cigarette promotes the development of cancer in laboratory cells. In contrast, smoke from a reference cigarette was positive for cancer-promoting activity, even at very low concentrations.
New research shows that at equivalent or higher doses of nicotine, acute exposure to e-cigarette vapour has very limited impact on gene expression compared to cigarette smoke.
Top scientists from BAT headed to Maryland, USA to present new research at the Society of Toxicology (SOT) Annual Meeting.
A new study predicts that when e-cigarettes are available as alternative to cigarettes, by 2050 the 32% of smokers in the UK that otherwise would have continued smoking would have completely switched to e-cigarettes.
Key scientists from British American Tobacco (BAT) presented their latest research at the Society for Research on Nicotine and Tobacco (SRNT) Annual Meeting in Florence, Italy earlier this month.
New research indicates that glo, a commercial tobacco heating product (THP), has less of an impact on indoor air quality than cigarette smoke.
The use of citric acid in e-liquids needs to be investigated to further understand its potential to form potentially harmful anhydrides in the vapour.
5-step approach to establishing whether tobacco is being combusted or heated in a tobacco-heating product (THP) is proposed.
Two new Adverse Outcome Pathways (AOPs), developed jointly by British American Tobacco (BAT) and Philip Morris International (PMI), are featured in a special issue of Applied In Vitro Toxicology (AIVT) focusing on the in vitro evaluation of next-generation nicotine products.
Dr Marianna Gaca and Dr James Murphy were both invited to present at the National Academy of Sciences in Washington DC last week, at a committee reviewing the health effects of Electronic Nicotine Delivery Systems (ENDS).
New research reveals changes in the expression levels of 123 genes when reconstituted lung tissue was exposed to cigarette smoke, compared to only two genes that could be confirmed following exposure to an e-cigarette (Vype ePen) aerosol.
E-cigarette vapour does not damage DNA, even at doses 28 times that of equivalent smoke exposure.
Several studies have compared the impact of e-cigarette vapour with that of cigarette smoke on cells and found that vapour has little or no effect.
New research proves that e-cigarette aerosol droplets are effectively delivered to cell surfaces in lab-based biological tests.